SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,125 | -11.8% | 1,822 | +0.1% | 0.00% | – |
| Q2 2023 | $47,747 | +103697.8% | 1,821 | +1.2% | 0.00% | – |
| Q1 2023 | $46 | -2.1% | 1,800 | 0.0% | 0.00% | – |
| Q4 2022 | $47 | -99.9% | 1,800 | -0.4% | 0.00% | – |
| Q3 2022 | $43,000 | -2.3% | 1,807 | +1.5% | 0.00% | – |
| Q2 2022 | $44,000 | -10.2% | 1,780 | +107.0% | 0.00% | – |
| Q1 2022 | $49,000 | -31.0% | 860 | -32.8% | 0.00% | -100.0% |
| Q4 2021 | $71,000 | -41.8% | 1,280 | -33.3% | 0.00% | 0.0% |
| Q3 2021 | $122,000 | -22.8% | 1,920 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $158,000 | +43.6% | 1,920 | +28.0% | 0.00% | 0.0% |
| Q1 2021 | $110,000 | +0.9% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $109,000 | +127.1% | 1,500 | +50.0% | 0.00% | – |
| Q3 2020 | $48,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |